Company: PHAT
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034183
Chunk: 128

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 16
Chunk 128
---
 Act of 1934, as amended

    X

    31.2
     
    Certification of Principal Financial Officer of Phathom Pharmaceuticals, Inc., as required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended

    X

    32.1*
     
    Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    X

    32.2*
     
    Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    X

    97#
     
    Policy for Recovery of Erroneously Awarded Compensation
     
    10-K
     
    3-7-2024
     
    97

    101.INS
     
    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document

    X

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

    X

    104
     
    Cover Page formatted as Inline XBRL and contained in Exhibit 101

    X

# Indicates management contract or compensatory plan.  

† Portions of this exhibit have been omitted for confidentiality purposes.

* These certifications are being furnished solely to accompany this annual report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing. 

^ Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplementally a copy of any omitted exhibit or schedule upon request by the SEC.

149